16:09 EST Soleno Therapeutics files automatic mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SLNO:
- Best-Performing Stocks of 2023: Can They Keep On Rolling?
- Soleno Therapeutics’ CEO Bhatnagar sells $3.3M in company shares
- Oppenheimer, Wedbush say buy these biotech stocks for 2024
- Soleno Therapeutics assumed with a Buy rating, $40 target at Guggenheim
- Soleno Therapeutics assumed with a Buy at Guggenheim